📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. (2018)

First Author: Xue K

Attributed to: Developing rhodopsin gene therapy to treat dominant retinitis pigmentosa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-018-0185-5

PubMed Identifier: 30297895

Publication URI: http://europepmc.org/abstract/MED/30297895

Type: Journal Article/Review

Volume: 24

Parent Publication: Nature medicine

Issue: 10

ISSN: 1078-8956